Reminyl is prescribed to treat Alzheimer’s disease. It has also been prescribed to treat mild cognitive impairment, although it has not been approved by the FDA for such use. Reminyl is manufactured by Johnson & Johnson and was approved by the FDA in 2001. It has been approved in 69 countries for treatment of Alzheimer’s.

In two clinical trials, it was seen that patients using Reminyl had an increased risk of heart attack and stroke compared to patients who took a placebo. The trial lasted two year, and in that time, 15 patients taking Reminyl died—compared to five patients taking placebos who died during the time period. Most of these deaths were caused by heart attack or stroke.

/* Css */ /* Form */

Free Consultation

Contact Jacoby & Meyers
Dangerous Drug Lawyers

Call us Today 800-977-5614

Have you or your loved one suffered an injury?
Yes No
Was Medical Treatment required for the injury?
Yes No
By submitting this form, I agree to be contacted by an attorney from Jacoby & Meyers or one of it sponsors and I hereby acknowledge that I have read the Terms and Condition and I agree to all of its terms and conditions.

*Required Fields

Dangerous Drugs Listing